Tevogen Bio Holdings Stock Alpha and Beta Analysis

TVGN Stock   1.17  0.06  5.41%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Tevogen Bio Holdings. It also helps investors analyze the systematic and unsystematic risks associated with investing in Tevogen Bio over a specified time horizon. Remember, high Tevogen Bio's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Tevogen Bio's market risk premium analysis include:
Beta
(0.62)
Alpha
0.14
Risk
7.34
Sharpe Ratio
0.0661
Expected Return
0.49
Please note that although Tevogen Bio alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Tevogen Bio did 0.14  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Tevogen Bio Holdings stock's relative risk over its benchmark. Tevogen Bio Holdings has a beta of 0.62  . As returns on the market increase, returns on owning Tevogen Bio are expected to decrease at a much lower rate. During the bear market, Tevogen Bio is likely to outperform the market. At this time, Tevogen Bio's Enterprise Value Over EBITDA is very stable compared to the past year. As of the 15th of March 2025, Enterprise Value Multiple is likely to grow to 9,220, though Book Value Per Share is likely to grow to (0).

Enterprise Value

1.15 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Tevogen Bio Backtesting, Tevogen Bio Valuation, Tevogen Bio Correlation, Tevogen Bio Hype Analysis, Tevogen Bio Volatility, Tevogen Bio History and analyze Tevogen Bio Performance.

Tevogen Bio Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Tevogen Bio market risk premium is the additional return an investor will receive from holding Tevogen Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Tevogen Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Tevogen Bio's performance over market.
α0.14   β-0.62

Tevogen Bio expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Tevogen Bio's Buy-and-hold return. Our buy-and-hold chart shows how Tevogen Bio performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Tevogen Bio Market Price Analysis

Market price analysis indicators help investors to evaluate how Tevogen Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Tevogen Bio shares will generate the highest return on investment. By understating and applying Tevogen Bio stock market price indicators, traders can identify Tevogen Bio position entry and exit signals to maximize returns.

Tevogen Bio Return and Market Media

The median price of Tevogen Bio for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 1.25 with a coefficient of variation of 16.76. The daily time series for the period is distributed with a sample standard deviation of 0.21, arithmetic mean of 1.26, and mean deviation of 0.18. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Tevogen Bios Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
02/10/2025
2
Tevogen Bio CEO Congratulates RFK Jr. on His Confirmation as Secretary of the HHS Echoes Commitment to Innovation and Affordability for Americans
02/13/2025
3
Tevogen Bio CEO Addresses Short Selling and Its Potential Impact on the Nations Health and Prosperity
02/14/2025
4
Tevogen Bios First Trading Year Efficiency 600 percent Higher Market Cap Per Team Member, 79 percent ...
02/21/2025
5
Tevogen Bio Founder and CEO Dr. Ryan Saadi Named to 2025 NJBIZ Power 100, Celebrating ...
02/28/2025
6
Which Biotechnology Firm Leads in Innovation and Financial Strength
03/03/2025
7
Disposition of 110659 shares by Flomenberg Neal of Tevogen Bio at 1.21 subject to Rule 16b-3
03/05/2025
8
Disposition of 88519 shares by Flomenberg Neal of Tevogen Bio at 1.1 subject to Rule 16b-3
03/06/2025
9
Tevogen Bios CIO Head of Tevogen.AI, Mittul Mehta, Featured Speaker at Proskauers AI Discussion Panel
03/07/2025
10
Disposition of 70252 shares by Flomenberg Neal of Tevogen Bio at 1.05 subject to Rule 16b-3
03/11/2025

About Tevogen Bio Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Tevogen or other stocks. Alpha measures the amount that position in Tevogen Bio Holdings has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

Tevogen Bio Investors Sentiment

The influence of Tevogen Bio's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Tevogen. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Tevogen Bio's public news can be used to forecast risks associated with an investment in Tevogen. The trend in average sentiment can be used to explain how an investor holding Tevogen can time the market purely based on public headlines and social activities around Tevogen Bio Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Tevogen Bio's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Tevogen Bio's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Tevogen Bio's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Tevogen Bio.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tevogen Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tevogen Bio's short interest history, or implied volatility extrapolated from Tevogen Bio options trading.

Build Portfolio with Tevogen Bio

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Tevogen Bio Holdings is a strong investment it is important to analyze Tevogen Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tevogen Bio's future performance. For an informed investment choice regarding Tevogen Stock, refer to the following important reports:
Tevogen Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Tevogen Bio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Tevogen Bio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...